索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 中国知网(CNKI)
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 期刊摘要索引目录
  • OCLC-WorldCat
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Long Noncoding RNAs and Human Osteosarcoma

Arshad Ali, Lifang Hu, Airong Qian,Chu Chen and Tuanmin Yang

Osteosarcoma is the most commonly diagnosed malignancies in children and adolescents, pathologically characterized by spindle cells and deviant osteoid formation. Although significant evidences in therapeutic strategies have been accomplished, the conclusion is still unclear for the critical metastatic or persistent osteosarcoma. Therefore, it is essential to develop novel and effective biomarkers or therapeutic targets for diagnosis of osteosarcoma. Long noncoding RNAs (lncRNAs), as a novel class of noncoding RNA, are composed of transcripts longer than 200 nucleotides and play critical roles in development and progression of various cancers including osteosarcoma. LncRNAs are mainly involved in different biological process such cell growth, transcription, translation, epigenetic regulation, splicing, chromosome dosage compensation, imprinting, nuclear, cytoplasmic trafficking and cell cycle control. LncRNAs may act as oncogenic or tumor suppressive that can modulate osteosarcoma pathogenesis including cell growth, migration, proliferation, metastasis, invasion and cell apoptosis. In this review, we summarize the current knowledge of lncRNAs and its critical role in progression of osteosarcoma. It will be helpful for researchers to evaluate the functional role of lncRNAs in the development of osteosarcoma and enhance the efficacy of therapeutic treatment modalities.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证